Aeglea BioTherapeutics, Inc.
USD12.01
+0.75 (+6.66%)
CEO
Jonathan D. Alspaugh
IPO Date
2016-04-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$10.87
Prev. Close
$11.26
Day Low
$10.69
Day High
$12.34
52W Low
$2.66
52W High
$24.00
Market Cap
$0.05B
Volume
0.04M
| Disposed |
| 3,435,480 |
| $0.00 |
| 11 Dec 2023 | Fairmount Funds Management LLC | director, 10 percent owner: | A-Award | Acquired | 16,667 | $0.00 |
| 8 Dec 2023 | Albers Jeffrey W. | director | A-Award | Acquired | 50,000 | $10.39 |
| 8 Dec 2023 | Albers Jeffrey W. | director | C-Conversion | Acquired | 34,360 | $0.00 |
| 8 Dec 2023 | Albers Jeffrey W. | director | C-Conversion | Disposed | 859 | $0.00 |
| 8 Dec 2023 | Albers Jeffrey W. | director | Disposed | 34,360 | $0.00 |
| 28 Nov 2023 | Fairmount Funds Management LLC | director, 10 percent owner: | C-Conversion | Acquired | 3,435,480 | $0.00 |
| 28 Nov 2023 | Fairmount Funds Management LLC | director, 10 percent owner: | C-Conversion | Disposed | 85,887 | $0.00 |
| 27 Nov 2023 | Turtle Cameron | director, officer: Chief Executive Officer | C-Conversion | Acquired | 723,440 | $0.00 |